


To invest in a concentrated portfolio of approximately 30-80 stocks of companies incorporated in emerging markets, and whose securities are listed or traded on a recognised market.
| Name | % Net Assets |
|---|---|
| Petrobras | 5.2% |
| Teva Pharmaceuticals | 4.7% |
| China Mobile | 4.1% |
| Vale On ADR | 4.0% |
| Ind. & Comm. Bank of China | 3.9% |
| Sasol | 3.7% |
| Reliance Industries | 3.7% |
| OAO Gazprom | 3.5% |
| China Life Insurance | 3.0% |
| Samsung Electronics | 2.9% |
| Key | % Net Assets |
|---|---|
| 5.2% | |
| 4.7% | |
| 4.1% | |
| 4.0% | |
| 82% |
| Date | n/a |
|---|---|
| Bid | 0.00 |
| Offer | 0.00 |
| Currency | n/a |
| Change | 0.00 |
| % | n/a |
| YTD change | 0.00 |
| YTD % | n/a |
| Fund Inception | 11/02/2009 |
|---|---|
| Fund Manager | n/a |
| TER | 1.07 (15-Jan-2014) |
| Minimum Investment | |
|---|---|
| Initial | n/a |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | 5.25% |
| Annual Mang't | 0.75% |
| Exit | n/a |
| Name | % |
|---|---|
| No risk data available. | |
You are here: research